Pancreatic Cancer Research

ResearcherWuhan Union HospitalNo recent work listed

Wei Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3873-5374; OpenAlex author ID A5101874772. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: 2 papers

Papers 4

  1. Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness. First author DOI 10.1038/s41598-017-06132-z↗
  2. Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-κB signaling pathway. First author DOI 10.1186/s12943-017-0627-6↗
  3. MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway. Co-author DOI 10.18632/oncotarget.5317↗
  4. ShRNA silencing glycogen synthase kinase-3 beta inhibits tumor growth and angiogenesis in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2011.10.033↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Heshui Wu · 3 shared papers, 2015–2017 · strength 0.19
  2. Chunyou Wang · 3 shared papers, 2012–2017 · strength 0.16
  3. Tao Liu · 3 shared papers, 2012–2017 · strength 0.15
  4. Shanmiao Gou · 3 shared papers, 2012–2017 · strength 0.15
  5. Li Wang · 2 shared papers, 2017 · strength 0.14
  6. Zhiyong Yang · 1 shared paper, 2017 · strength 0.08
  7. Tao Peng · 1 shared paper, 2017 · strength 0.08
  8. Tao Yin · 1 shared paper, 2017 · strength 0.06
  9. Ping Fan · 1 shared paper, 2017 · strength 0.06
  10. Xin Jin · 1 shared paper, 2017 · strength 0.06
  11. Haijiao Yan · 1 shared paper, 2015 · strength 0.05
  12. Tongling Wang · 1 shared paper, 2012 · strength 0.03
  13. Li Wang · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.